NCT01511731

Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions

Open-label, Randomized, 2-way Crossover Study to Compare the Bioavailability of Reddy Cheminor and Merck &Co, Pepcid Famotidine Tablets 40 mg Under Fasting Conditions.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Dr. Reddy's Laboratories Limited · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The objective of this study was to compare the single-dose relative bioavailability of Reddy Cheminor and Merck \&Co, pepcid 40 mg famotidine tablets under fasting conditions.

Detailed description

Detailed Description : The study was conducted as an open-label, randomized, single-dose, 2-way crossover, relative bioavailability study performed on 30 healthy adult male volunteers. A total of 30 subjects completed the clinical phase of the study. Single oral 40 mg doses were separated by a washout period of 7 days.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Famotidine	Famotidine Tablets 40 mg
DRUG	Pepcid	40mg tablets

Timeline

• Start date: 1998-10-01
• Primary completion: 1998-10-01
• Completion: 1998-10-01
• First posted: 2012-01-19
• Last updated: 2012-01-19

Locations

1 site across 1 country: Canada